Corrigendum to "The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells" [Chem. Biol. Interact. 302 (2019) 28-35].

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Chemico-Biological Interactions

• Publication date

  2019-09-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cbi.2019.108812PMID 31495450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• FOXP3 inhibits proliferation and migration by competitively inhibiting YAP1 in nasopharyngeal carcinoma.

  2024cites this paper
• Spectroscopic studies under properties of chlorpromazine conjugated to gold nanoparticles.

  2024cites this paper
• Novel Tetracyclic Azaphenothiazines with the Quinoline Ring as New Anticancer and Antibacterial Derivatives of Chlorpromazine

  2024cites this paper
• Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications

  2023cites this paper
• Recent progress of mechanosensitive mechanism on breast cancer.

  2023cites this paper
• Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies

  2023cites this paper
• The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand–Receptor Systems and Depends on Tumor Intrinsic Subtype

  2023cites this paper
• The Role of Dopamine in Repurposing Drugs for Oncology

  2023cites this paper
• Targeting Prostate Cancer, the ‘Tousled Way’

  2023cites this paper
• Emerging agents that target signaling pathways in cancer stem cells

  2020cites this paper
• Clinical trials on combination of repurposed drugs and anticancer therapies

  2020cites this paper